Randomized Controlled Trial to Evaluate the Optimal Timing of Surgical Antimicrobial Prophylaxis
Condition: Surgical Site InfectionInterventions: Procedure: Early administration of SAP (Cefuroxime (plus metronidazole in colorectal surgery)) in anesthetic room (75 to 30 minutes prior to skin incision); Procedure: Late administration of SAP (Cefuroxime (plus metronidazole in colorectal surgery)) in the operating theatre (within 30 minutes prior to skin incision)Sponsors: University Hospital, Basel, Switzerland; Cantonal Hospital of Aarau, SwitzerlandRecruiting - verified September 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 5, 2013 Category: Research Source Type: clinical trials
Randomized Controlled Trial to Evaluate the Optimal Timing of Surgical Antimicrobial Prophylaxis
Condition: Surgical Site InfectionInterventions: Procedure: Early administration of SAP (Cefuroxime (plus metronidazole in colorectal surgery)) in anesthetic room (75 to 30 minutes prior to skin incision); Procedure: Late administration of SAP (Cefuroxime (plus metronidazole in colorectal surgery)) in the operating theatre (within 30 minutes prior to skin incision)Sponsors: University Hospital, Basel, Switzerland; Cantonal Hospital of Aarau, SwitzerlandRecruiting - verified March 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 5, 2013 Category: Research Source Type: clinical trials
Randomized Controlled Trial to Evaluate the Optimal Timing of Surgical Antimicrobial Prophylaxis
Condition: Surgical Site InfectionInterventions: Procedure: Early administration of SAP (Cefuroxime (plus metronidazole in colorectal surgery)) in anesthetic room (75 to 30 minutes prior to skin incision); Procedure: Late administration of SAP (Cefuroxime (plus metronidazole in colorectal surgery)) in the operating theatre (within 30 minutes prior to skin incision)Sponsors: University Hospital, Basel, Switzerland; Cantonal Hospital of Aarau, SwitzerlandRecruiting - verified September 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 5, 2013 Category: Research Source Type: clinical trials
Antibiotic Prophylaxis for Transrectal Prostate Biopsy
Condition: InfectionInterventions: Drug: Ciprofloxacin; Drug: trimethoprim-sulfamethoxazole; Drug: cefuroxime; Drug: ceftriaxone; Drug: gentamicin; Drug: amikacin; Drug: aztreonam; Drug: imipenem; Drug: ceftriaxone; Drug: gentamicin; Drug: amikacin; Drug: aztreonam; Drug: imipenemSponsor: Northwestern UniversityRecruiting - verified September 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 7, 2012 Category: Research Source Type: clinical trials
Antibiotic Prophylaxis for Transrectal Prostate Biopsy
Condition: InfectionInterventions: Drug: Ciprofloxacin; Drug: trimethoprim-sulfamethoxazole; Drug: cefuroxime; Drug: ceftriaxone; Drug: gentamicin; Drug: amikacin; Drug: aztreonam; Drug: imipenem; Drug: ceftriaxone; Drug: gentamicin; Drug: amikacin; Drug: aztreonam; Drug: imipenemSponsor: Northwestern UniversityRecruiting - verified March 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 9, 2012 Category: Research Source Type: clinical trials
